Physician profile
Shepard Urbahn
NPI 1831662717
$1,559.45
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,063 · 2022: $496.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $309.98 | 2021 | |
| Abbvie INC. | $204.74 | 2021-2022 | |
| Stimwave Technologies Incorporated | $139.76 | 2022 | |
| Radius Health, INC. | $139.39 | 2021-2022 | |
| Redhill Biopharma INC. | $117.25 | 2021-2022 | |
| Tersera Therapeutics LLC | $93.31 | 2021-2022 | |
| Medtronic, INC. | $91.81 | 2021-2022 | |
| Novo Nordisk INC | $61.55 | 2021-2022 | |
| Grt US Holding, INC. | $60.33 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.02 | 2021-2022 | |
| Amgen INC. | $55.73 | 2021-2022 | |
| Corcept Therapeutics | $32.57 | 2022 | |
| Pacira Therapeutics, INC. | $29.89 | 2021 | |
| Dexcom, INC. | $28.05 | 2021 | |
| Arbor Pharmaceuticals, INC. | $20.08 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $19.21 | 2021 | |
| Ibsa Pharma INC. | $18.43 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.70 | 2021 | |
| Almatica Pharma LLC | $17.15 | 2021 | |
| Xeris Pharmaceuticals, INC. | $16.67 | 2022 | |
| Nalu Medical, INC. | $15.34 | 2021 | |
| Mannkind Corporation | $12.49 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shepard Urbahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.